158 - Surgical Issues in Pediatric Infectious Diseases

Friday, October 18, 2024

1:45 PM – 3:00 PM US PT

Location: 515 A

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Latania Logan, MD, MSPH

Marcus Professor of Pediatric Infectious Diseases, Professor of Pediatrics
Emory University School of Medicine
Atlanta, Georgia, United States
Ravi Jhaveri, MD

Professor of Pediatrics
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, IL, United States

Faculty(s)

Jason Newland, MD (he/him/his)

Professor of Pediatrics
Washington University School of Medicine
Columbus, OH, United States
Allison Messina, MD (she/her/hers)

Pediatric Infectious Diseases Physician
Johns Hopkins All Children's Hospital
Elisabeth Ference, MD, MPH

Otolaryngology Head and Neck Surgeon
Children's Hospital Los Angeles

Disclosure(s):

Latania K. Logan, MD, MSPH: No financial relationships to disclose

Ravi Jhaveri, MD: AstraZenca: Advisor/Consultant (Ongoing); CSL Seqirus: Advisor/Consultant (Ongoing); Gilead Biosciences: Advisor/Consultant (Ongoing); GSK: Grant/Research Support (Ongoing); Pediatric Infectious Diseases Society: editorial stipend (Ongoing); Sanofi Pasteur LLC: Advisor/Consultant (Ongoing); UpToDate Wolters Kluwer Health: royalties (Ongoing)

Jason Newland, MD: AHRQ: Grant/Research Support (Ongoing); Merck and Company, Inc.: Grant/Research Support (Terminated); Pfizer, Inc.: Grant/Research Support (Ongoing)

Allison Messina, MD: No financial relationships to disclose

Elisabeth Ference, MD, MPH: OptiNose Inc.: Advisor/Consultant (Ongoing); Regeneron, Inc: Advisor/Consultant (Ongoing)

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe current regimens, durations and strategies for peri-operative antibiotic prophylaxis;
describe changes in epidemiology and management of children with post operative spinal hardware infections;
analyze the timing and frequency of debridement in invasive fungal sinusitis.

Presentations:

1:45 PM – 2:10 PM US PT

Re-thinking Regimens and Duration for Peri-Operative Prophylaxis
Speaker: Jason Newland, MD (he/him/his) – Washington University School of Medicine
2:10 PM – 2:35 PM US PT

Where are we with management of pediatric spinal hardware infections?
Speaker: Allison Messina, MD (she/her/hers) – Johns Hopkins All Children's Hospital
2:35 PM – 3:00 PM US PT

When and How Often Do We Need to Debride: ENT Management of Invasive Fungal Sinusitis in Children
Speaker: Elisabeth Ference, MD, MPH – Children's Hospital Los Angeles